FDA-Inspected Site

Dendreon Pharmaceuticals LLC

6 FDA inspections are on record for Dendreon Pharmaceuticals LLC in Seal Beach, United States.

483· Form 483 issued

Seal Beach, United States · Last updated July 9, 2026

Overview

  • 6 FDA inspections are on record.
  • 6 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-03-25.

At a glance

Inspections

6

Form 483s

6

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
16 Mar 2026 – 25 Mar 2026Biologics483View 483 →
2 Aug 2023 – 10 Aug 2023Biologics483View 483 →
28 Oct 2019 – 8 Nov 2019Biologics483View 483 →
9 Jan 2018 – 19 Jan 2018Biologics483View 483 →
14 Jan 2016 – 22 Jan 2016Biologics483On file
8 Apr 2011Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

25 Mar 2026
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez

25 Mar 2026
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez

25 Mar 2026
21 CFR 211.115(b)

Reprocessing/quality control unit

Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez

25 Mar 2026
21 CFR 211.188(b)

Batch production and Batch Control Record Requirements

Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez

25 Mar 2026
21 CFR 211.192

Written record of investigation incomplete

Cited by Sony Mathews, Esther A Ofori, Emily B Camire, Lizaida Perez

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations6x
21 CFR 211.113(b)Cited across public-safe Form 483 observations5x
21 CFR 211.100(a)Cited across public-safe Form 483 observations2x
21 CFR 211.101(d)Cited across public-safe Form 483 observations2x
21 CFR 211.142Cited across public-safe Form 483 observations2x
21 CFR 211.188(b)(7)Cited across public-safe Form 483 observations2x
21 CFR 211.42(c)(1)Cited across public-safe Form 483 observations2x
21 CFR 211.42(c)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.46(b)Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)(2)Cited across public-safe Form 483 observations2x
21 CFR 600.80(b)Cited across public-safe Form 483 observations2x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.115(b)Cited across public-safe Form 483 observations1x
21 CFR 211.122(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(8)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(e)Cited across public-safe Form 483 observations1x
21 CFR 211.94(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Dendreon Pharmaceuticals LLC's 6 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat